Acadia Healthcare Company, Inc.
Business
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services operating a large network of facilities across the United States and Puerto Rico. The company offers acute inpatient psychiatric care, specialty treatment programs focused on substance use disorder recovery, comprehensive treatment centers with medication-assisted treatment, and residential treatment centers for children and adolescents. Revenue is diversified across government payors (Medicaid and Medicare) and commercial insurers, with growth driven through facility expansions, joint venture partnerships, de novo openings, and acquisitions.
Summary from 10-K filed 2026-02-27
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 3,313 | 3,154 | 2,929 | 2,610 | 2,314 | |
| Salaries, wages and benefits (including equity-based compensation expense of $31,708, $37,113, and $32,289, respectively) | 1,821 | 1,691 | 1,572 | 1,393 | 1,244 | |
| Professional fees | 195 | 190 | 176 | 158 | 137 | |
| Supplies | 118 | 113 | 106 | 100 | 91 | |
| Rents and leases | 48 | 48 | 47 | 45 | 39 | |
| Other operating expenses | 553 | 441 | 389 | 349 | 301 | |
| Income from provider relief fund | — | — | −6 | −21 | −18 | |
| Depreciation and amortization | 189 | 150 | 132 | 118 | 107 | |
| Interest expense, net | 139 | 116 | 82 | 70 | 77 | |
| Debt extinguishment costs | 1 | — | — | — | 25 | |
| Legal settlements expense | 151 | — | 394 | — | — | |
| Loss on impairment | 1,008 | 17 | 10 | — | 24 | |
| Gain on sale of property | −9 | — | −10 | — | — | |
| Transaction, legal and other costs | 164 | 47 | 62 | 24 | 13 | |
| Total expenses | 4,379 | 2,812 | 2,954 | 2,236 | 2,039 | |
| (Loss) income before income taxes | −1,066 | 342 | −25 | 374 | 276 | |
| Provision for (benefit from) income taxes | 26 | 77 | −10 | 94 | 68 | |
| Net (loss) income | −1,092 | 264 | −16 | 280 | 196 | |
| Net income attributable to noncontrolling interests | −11 | −9 | −6 | −7 | −5 | |
| Net (loss) income attributable to Acadia Healthcare Company, Inc. | −1,103 | 256 | −22 | 273 | 191 | |
| Basic (per share) | −12.16 | 2.79 | −0.24 | 3.05 | 2.15 | |
| Diluted (per share) | −12.16 | 2.78 | −0.24 | 2.98 | 2.1 | |
| Basic (shares) | 91 | 92 | 91 | 90 | 89 | |
| Diluted (shares) | 91 | 92 | 91 | 92 | 91 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 133 | 76 | 100 | 98 | 134 | |
| Accounts receivable, net | 441 | 365 | 361 | 322 | 281 | |
| Other current assets | 240 | 136 | 134 | 86 | 80 | |
| Total current assets | 814 | 577 | 596 | 506 | 495 | |
| Property and equipment, net | 3,111 | 2,853 | 2,267 | 1,952 | 1,771 | |
| Goodwill | 1,296 | 2,265 | 2,226 | 2,223 | 2,200 | |
| Intangible assets, net | 97 | 70 | 73 | 76 | 70 | |
| Deferred tax assets | 3 | 21 | 7 | 3 | 3 | |
| Operating lease right-of-use assets | 134 | 118 | 118 | 135 | 134 | |
| Other assets | 73 | 52 | 73 | 93 | 95 | |
| Total assets | 5,527 | 5,957 | 5,359 | 4,988 | 4,768 | |
| Current portion of long-term debt | 28 | 77 | 29 | 21 | 19 | |
| Accounts payable | 150 | 233 | 156 | 105 | 99 | |
| Accrued salaries and benefits | 189 | 155 | 142 | 125 | 138 | |
| Current portion of operating lease liabilities | 21 | 25 | 26 | 26 | 23 | |
| Other accrued liabilities | 137 | 88 | 532 | 111 | 126 | |
| Total current liabilities | 525 | 578 | 886 | 388 | 405 | |
| Long-term debt | 2,472 | 1,880 | 1,343 | 1,365 | 1,479 | |
| Deferred tax liabilities | 67 | 84 | 2 | 93 | 74 | |
| Operating lease liabilities | 122 | 102 | 101 | 116 | 117 | |
| Other liabilities | 202 | 122 | 140 | 125 | 111 | |
| Total liabilities | 3,387 | 2,766 | 2,471 | 2,087 | 2,185 | |
| Redeemable noncontrolling interests | 192 | 117 | 106 | 88 | 65 | |
| Preferred stock, $0.01 par value; 10,000,000 shares authorized, no shares issued | — | — | — | — | — | |
| Common stock, $0.01 par value; 180,000,000 shares authorized;90,452,843 and 91,775,264 issued and outstanding as of December 31, 2025 and 2024, respectively | 905,000 | 918,000 | 913,000 | 899,000 | 890,000 | |
| Additional paid-in capital | 2,714 | 2,685 | 2,649 | 2,658 | 2,636 | |
| (Accumulated deficit) retained earnings | −766 | 387 | 132 | 153 | −120 | |
| Total equity | 1,949 | 3,074 | 2,782 | 2,813 | 2,517 | |
| Total liabilities and equity | 5,527 | 5,957 | 5,359 | 4,988 | 4,768 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Amortization of debt issuance costs | 5 | 4 | 3 | 3 | 4 | |
| Deferred income taxes | 1 | 68 | −94 | 17 | 12 | |
| Non-cash legal settlements expense | 4 | — | 394 | — | — | |
| Other | 2 | −5 | 3 | 3 | 491,000 | |
| Accounts receivable, net | −75 | −2 | −39 | −42 | 2 | |
| Other current assets | −47 | −7 | 9 | −18 | 2 | |
| Other assets | −11 | 521,000 | 989,000 | 2 | −11 | |
| Accounts payable and other accrued liabilities | 15 | −421 | 17 | 5 | 6 | |
| Accrued salaries and benefits | 27 | 12 | 17 | 7 | 10 | |
| Other liabilities | 83 | 12 | 11 | 15 | −15 | |
| Government relief funds | — | — | −9 | −39 | −38 | |
| Net cash provided by operating activities | 132 | 130 | 462 | 381 | 374 | |
| Cash paid for acquisitions, net of cash acquired | −8 | −54 | −349,000 | −10 | −139 | |
| Cash paid for capital expenditures | −572 | −690 | −424 | −296 | −245 | |
| Proceeds from sale of property and equipment | 24 | 10 | 29 | 7 | 3 | |
| Other | −90,000 | −3 | −2 | −7 | −1 | |
| Net cash used in investing activities | −556 | −736 | −397 | −306 | 1,013 | |
| Borrowings on long-term debt | 1,200 | 350 | — | — | 425 | |
| Principal payments on revolving credit facility | −1,035 | −15 | −35 | −95 | −330 | |
| Principal payments on long-term debt | −12 | −56 | −21 | −19 | −8 | |
| Repayment of long-term debt | −671 | — | — | — | −2,228 | |
| Payment of debt issuance costs | −19 | −2 | — | — | −8 | |
| Repurchase of shares for payroll tax withholdings, net of proceeds from stock option exercises | −4 | −1 | −44 | −6 | 16 | |
| Repurchase of common stock | −50 | — | — | — | — | |
| Contributions from noncontrolling partners in joint ventures | 9 | 5 | 3 | 15 | 5 | |
| Distributions to noncontrolling partners in joint ventures | −4 | −3 | −5 | −1 | −2 | |
| Cash paid for contingent consideration | −2 | — | — | — | — | |
| Other | −90,000 | — | 37,000 | 52,000 | −7 | |
| Net cash provided by (used in) financing activities | 481 | 583 | −63 | −111 | −1,637 | |
| Net increase (decrease) in cash and cash equivalents | 57 | −24 | 2 | −36 | −245 | |
| Cash paid for interest | 125 | 113 | 81 | 66 | 94 | |
| Cash paid for income taxes | 30 | 28 | 66 | 86 | 79 | |
| Assets acquired, excluding cash | 54 | 59 | 7 | 11 | 176 | |
| Liabilities assumed | −893,000 | −4 | −128,000 | −1 | −37 | |
| Contingent consideration issued in connection with an acquisition | — | −2 | — | — | — | |
| Redeemable noncontrolling interest resulting from an acquisition | −45 | — | −6 | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Acadia Healthcare Company, Inc.'s CIK number?
Acadia Healthcare Company, Inc.'s SEC CIK number is 0001520697 (1520697). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Acadia Healthcare Company, Inc.'s SEC filings?
All of Acadia Healthcare Company, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Acadia Healthcare Company, Inc. last report earnings?
Acadia Healthcare Company, Inc. (ACHC) most recently filed an earnings 8-K with the SEC on Apr 29, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001437749-26-013916). This is Acadia Healthcare Company, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Acadia Healthcare Company, Inc.'s most recent earnings 8-K?
Acadia Healthcare Company, Inc.'s latest earnings 8-K (Item 2.02) was filed Apr 29, 2026 under accession 0001437749-26-013916. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Acadia Healthcare Company, Inc.'s latest earnings 8-K →
Look up any company's CIK number →